Free Trial

Atlantic Coastal Acquisition Corp. II (ACABU) Competitors

$8.05 -2.95 (-26.82%)
(As of 11/12/2024)

ACABU vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying Atlantic Coastal Acquisition Corp. II stock or one of its competitors? The main competitors of Atlantic Coastal Acquisition Corp. II include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

Atlantic Coastal Acquisition Corp. II vs.

180 Life Sciences (NASDAQ:ATNFW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABU) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their community ranking, risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation.

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A

180 Life Sciences and Atlantic Coastal Acquisition Corp. II both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
Atlantic Coastal Acquisition Corp. IIN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A

In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
Atlantic Coastal Acquisition Corp. II Neutral

Summary

180 Life Sciences and Atlantic Coastal Acquisition Corp. II tied by winning 0 of the 0 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACABU vs. The Competition

MetricAtlantic Coastal Acquisition Corp. IIShell Companies IndustryFinancial SectorNASDAQ Exchange
Market CapN/A$45.09M$3.25B$8.80B
Dividend YieldN/A5.54%4.58%4.07%
P/E RatioN/A31.90440.8313.60
Price / SalesN/A1,008.103,270.2687.40
Price / CashN/A87.1448.1736.27
Price / BookN/A4.381.486.33
Net IncomeN/A-$3.19M$396.05M$225.93M
7 Day PerformanceN/A0.54%0.17%-0.96%
1 Month Performance-30.00%3.14%7.11%1.06%
1 Year Performance-23.55%-0.17%15.67%26.59%

Atlantic Coastal Acquisition Corp. II Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACABU
Atlantic Coastal Acquisition Corp. II
N/A$8.05
-26.8%
N/A-23.6%$0.00N/A0.004Gap Down
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A-25.0%$0.00N/A0.007
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.04
-20.6%
N/A-71.9%$0.00N/A0.002
AIMDW
Ainos
N/A$0.03
flat
N/AN/A$0.00$40,633.000.0040
ALVOW
Alvotech
N/A$3.10
-7.7%
N/A+105.3%$0.00$306.77M0.004
ALVO
Alvotech
2.2902 of 5 stars
$12.36
-0.5%
$18.00
+45.6%
+35.9%$0.00$93.38M-6.711,026
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.08
flat
N/A+77.4%$0.00N/A0.004
BFRIW
Biofrontera
N/A$0.05
-11.7%
N/A+179.9%$0.00$35.24M0.0070
BTMDW
biote
N/A$0.50
flat
N/AN/A$0.00$187.23M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.33
-7.1%
N/A-80.6%$0.00N/A0.008Gap Down

Related Companies and Tools


This page (NASDAQ:ACABU) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners